glp-1 medications and anesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general GLP-1 and Surgery: What Patients

Liu K, Lin S, Gao X, Wang S, Liu Y, Liu Q et al (2023) Reduced allergenicity of shrimp (Penaeus vannamei) by altering the protein fold, digestion susceptibility, and allergen epitopes

Instead, the disease and context specific loss or disruption of astrocyte functions can result in the accumulation of various potentially toxic metabolites or in the loss of support functions for neurones or synapses or in (the deadliest) combination of both

It has been established through clinical trials that GLP-1 receptor agonists (liraglutide and semaglutide) have proven to be consistently useful in lowering body weight, enhancing glycaemic control, and reducing cardiovascular risk [7,8,9].Nevertheless, since GLP-1 receptor agonists have the capability to work on several central nervous pathways, including the one controlling appetite, reward circuits, and the pancreatic-enteric-brain axis, the potential psychological impact of such agonists has increased with time [10,11,12]

GLP-1 medication is not for everyone, and only a licensed healthcare provider can determine whether it is appropriate